|
As the healthcare sector is one of the most dynamic large segments of
GDP, it produces numerous start-up and small businesses. Wahackme principals have done considerable work in the healthcare
industry whether as an agent or as a principal in a venture capital or private equity capacity. Members of Wahackme Group have worked with many large successful healthcare companies - usually when
they were smaller. We are also fairly sector agnostic - having worked with equipment and device businesses as well as biotech,
pharma and service companies. Our principals have handled IPO's for Stryker, Alexion, Cambrex and Positron and have worked
on financings for Medarex, EntreMed, Health Dialog, TechRx, Minrad and Neuren, to name a few.
The following is a list of some of these assignments:
Neuren Pharmaceuticals, Ltd. | $6,700,000 PIPE | Careside,
Inc. | $15,000,000 Common Stock - IPO | Alexion Pharmaceuticals, Inc. | $21,000,000 Common Stock - IPO | Medarex, Inc. | $5,000,000 Common Stock | Positron Corporation | $15,000,000
Common Stock - IPO | Cambrex Corporation | $63,000,000 Common Stock - IPO | Stryker Corporation | $12,000,000 Common Stock
- IPO | Gynetics, Inc. | Advised on sale of a product line to Barr Laboratory | Omega Orthodontics, Inc. | Advised on sale of company to Pentegra Dental Corporation | International Vitamin Corporation | Advised
on acquisition of Hall Laboratories | Greenwich
Pharmaceuticals Inc. | Advised on the acquisition of Boston
Life Sciences | NuVim, Inc. | $4,900,000 Convertible Preferred Stock | Minrad, Inc. | $2,300,000
Convertible Preferred Stock | Health Dialog Services
Corporation | $10,000,000 Convertible Preferred Stock | TechRx Incorporated | $10,000,000 Convertible
Preferred Stock | PrISMedical Corporation | $3,500,000 Common Stock | Gynetics, Inc. | $11,500,000 Common
Stock | Careside, Inc. | $11,500,000 Common Stock | EntreMed, Inc. | $6,000,000 Common Stock | | | | | | | | | | | | | | | | |
Return to Industry Expertise
 |
 |
 |
|